SOX2 and benign neoplasm: Overall, for both Sox2 and Oct4, only immunostaining in the nuclei of the cancer cells was thought to be positive, whereas all the precancerous tissues and benign tumor tissues showed negative staining with significant differences (p < 0.01, Table 1, Figure 1).